Details for 2014162613

Up to date per 03.04.2026

Actions

Title / Product Name

Kombination aus einem Anti-CTLA4-Antikörper mit Etoposide für die synergistische Behandlung proliferativer Erkrankungen

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2014162613

EP Publication Number

2769737

E-Number

881172

Language

PCT Number

Publication Date

27.08.2014 A

05.04.2017 B1

Registration Date

05.04.2017

AT Publication Date

15.04.2017

Application Date

29.10.2009

Registration Number

Priorities

20.07.2009

226910 P

30.07.2009

462168

30.07.2009

PCT/US2009/052209

IPC

A61K 45/06 20060101AFI20161103BHEP

Maximum Duration of Protection

29.10.2029

Owner

Bristol-Myers Squibb CompanyRoute 206 and Province Line Road Princeton, NJ 08543US

Representative

Patentanwalt Mikšovsky KGBisamberger Straße 192100 KorneuburgAT

Inventor

Lee, Francis, Y.c/o Bristol-Myers Squibb Company Route 206 & Province Line Road Princeton, NJ New Jersey 08543US

Jure-Kunkel, Mariac/o Bristol-Myers Squibb Company Route 206 & Province Line Road Princeton, NJ New Jersey 08543US

Information about Fees